
Trimetazin MR Tablet
Marketer
Workcell Solutions Private Limited
Salt Composition
Trimetazidine (35mg)
Overview Trimetazin MR Tablet
Extended-release trimetazidine tablets are prescribed for angina pectoris, a type of chest pain stemming from heart conditions. This medication acts as a preventative measure against future angina episodes, but it's ineffective in halting an attack already in progress. It can be administered independently or alongside other cardiac medications, always as directed by your physician. Consistent daily use, at a time convenient for you—with or without food—is crucial for optimal efficacy. Dosage frequency may be adjusted by your doctor based on treatment response. Continuous use is vital for sustained benefit, even in symptom-free periods, helping to minimize future cardiac complications. Discontinuing treatment could lead to a recurrence of chest pain. Complementing medication with lifestyle improvements—such as smoking cessation, moderated alcohol consumption, a balanced diet, regular physical activity, and stress management—will significantly enhance heart health. Commonly reported side effects include lightheadedness, headaches, stomach upset, diarrhea, digestive discomfort, nausea, vomiting, skin rashes, itching, urticaria, and fatigue. Consult your doctor if these persist or are troublesome. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, pregnancy, breastfeeding status, and all other concurrent medications to your healthcare provider, as this medication may not be appropriate for everyone.
Primary Ingredients of Trimetazin MR Tablet
No text provided to rephrase.
Uses of Trimetazin MR Tablet
Managing Chest Pain Associated with Coronary Artery Disease
Major Benefits of Trimetazin MR Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trimetazin MR Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
Common Side effects of Trimetazin MR Tablet:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Trimetazin MR Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Trimetazin MR Tablet with food.
How Trimetazin MR Tablet works:
Trimetazidine modified-release tablets are used to treat angina. They reduce the heart's oxygen demand by altering its energy source from fatty acids to carbohydrates. This improves the heart's overall performance.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Trimetazin MR Tablets and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Pregnancy-related data on Trimetazin MR Tablet is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Trimetazin MR Tablet use while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Trimetazin MR Tablets can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these side effects manifest.
KidneyCAUTION
Patients with kidney impairment should use Trimetazin MR Tablet cautiously, potentially requiring dosage modification under medical supervision. Trimetazin MR Tablet is contraindicated in individuals with severe kidney disease.
LiverCONSULT YOUR DOCTOR
Data regarding Trimetazin MR Tablet use in patients with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Trimetazin MR Tablet :
Should you forget a Trimetazin MR Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Trimetazin MR Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzylamines |
| Developing Good Habits | No. |
| Treatment Category | Heart |
| Actions | Fatty acid regulator and sodium channel inhibitor |
